Discusses FDA Approval of Furoscix ReadyFlow for IV-Equivalent Diuretic Therapy in Fluid Overload July 24, 2026 9:00 ...

MannKind (NASDAQ:MNKD) said the U.S. Food and Drug Administration approved Furoscix ReadyFlow, an auto-injector designed to ...

Transformative delivery option that may support earlier management of worsening fluid overload with a self-administered option designed for use ...

FDA approved a subcutaneous furosemide autoinjector with IV-equivalent exposure for edema in adults with HF or CKD, expanding the Furoscix franchise beyond the on-body infusor. Rapid administration ...

The healthcare landscape is changing rapidly as medical innovation focuses not only on improving therapeutic outcomes but also on enhancing the methods of administration to patients. In this context, ...

Smart rings are a stylish and functional way to track your health data if you don’t like how bulky most wearables are. As ...

For shareholders in Carclo (CAR:30p), the past 16 months have been nothing if not dramatic. In late April 2025, the precision engineering group struck a refinancing deal to reduce its pension deficit ...

Okay. Very good. Well, we're all set to get started here. I know we're towards the tail end of the day. So thanks, everyone, for sticking with us. Thanks for joining us for the West management ...

Diabetes hardware company embecta aims to look beyond insulin and reshape itself into a more varied drug delivery provider—and it’s kick-starting that effort with the acquisition of a global ...

Soft and sustainable wearable bioelectronics are emerging as key platforms for personal health monitoring and digital healthcare. These systems can continuously acquire electrical, mechanical, and ...